NCT00385775View on ClinicalTrials.gov

Study of XIAP Antisense for Advanced Cancers

PHASE1TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions
Advanced Cancer
Interventions
DRUG

AEG35156

weekly IV solution infused over 2 hrs

Trial Locations (1)

M20 4BX

Christie Hospital NHS Trust, Manchester

Sponsors
All Listed Sponsors
lead

Aegera Therapeutics

INDUSTRY

NCT00385775 - Study of XIAP Antisense for Advanced Cancers | Biotech Hunter | Biotech Hunter